Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · Gmo

GMO International Developed Equity Allocation Fund Class III (GIOTX)

Ticker GIOTX · Since 2006-06-05 · · Holdings as of May 31, 2026

Expense ratio
0.63%$63/yr per $10k
5-yr return
+13.4%annualized
1-yr return
+43.7%as of Dec 2025
Net assets
$222.9Mall share classes
Holdings
4

Bottom line

Is GIOTX a good fund? The bottom line

GIOTX is the Class III share class of GMO International Developed Equity Allocation Fund, an actively managed allocation / balanced mutual fund from Gmo.

It charges 0.63% — about $63 a year on every $10,000 invested, cheaper than 77% of allocation / balanced funds we track.

It returned +43.7% over one year, +13.4% a year over five years, +10.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $223 million in net assets and 4 holdings, its largest position is GMO International Equity Fund (70.0%) and the top 10 make up 100% of the portfolio.

What stands out

  • Low cost: cheaper than 77% of allocation / balanced peers
  • 5-year return beat 99% of category peers

What to watch

  • Concentrated: top 10 holdings are 100% of assets

Updated Nov 19, 2026

What GIOTX invests in

Total return greater than that of its benchmark, the MSCI World ex USA Index.

The Fund is a fund of funds and invests primarily in equities traded in non-U.S. markets (including emerging markets) through its investment in Equity Funds and GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). The Fund also may invest directly in securities (including other underlying funds) and derivatives. GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class. An important component of those forecasts is GMOs expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value over a complete market cycle. GMO changes the Funds…

From the fund's prospectus (filed Oct 20, 2026).

GIOTX performance

Fund calendar-year total returns, 2015–2025 2015: −6.6%; 2016: +3.3%; 2017: +26.4%; 2018: −19.7%; 2019: +24.4%; 2020: +7.4%; 2021: +11.1%; 2022: −12.4%; 2023: +21.0%; 2024: +10.6%; 2025: +43.7% −7% 2015 +3% 2016 +26% 2017 −20% 2018 +24% 2019 +7% 2020 +11% 2021 −12% 2022 +21% 2023 +11% 2024 +44% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
GIOTX+43.7%+13.4%+10.1%
Allocation / Balanced median+11.0%+5.7%+6.7%

Source: Fund prospectus, as of Dec 31, 2025

Full GIOTX performance history →

What GIOTX costs

On a $10,000 investment, GIOTX's 0.63% expense ratio costs about $63 a year. The prospectus estimates $842 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full GIOTX fee table →

GIOTX top 10 holdings

#Holding% of fund
1GMO International Equity Fund70.04%
2GMO International Opportunistic Value Fund22.68%
3GMO-Usonian Japan Value Creation Fund7.22%
4State Street Global Advisors0.11%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 100% of the fund. See all top 25 holdings and asset mix →

Alternatives to GIOTX

More funds like GIOTX →

GIOTX FAQ

What is the expense ratio of GIOTX?
GIOTX's expense ratio is 0.63%, which works out to about $63 a year for every $10,000 invested. The prospectus estimates total costs of $842 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is GIOTX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 77% of allocation / balanced peers; 5-year return beat 99% of category peers; concentrated: top 10 holdings are 100% of assets. This is general information, not personalized advice.
What does GIOTX hold?
GIOTX's largest holdings are GMO International Equity Fund (70.0%), GMO International Opportunistic Value Fund (22.7%), GMO-Usonian Japan Value Creation Fund (7.2%), State Street Global Advisors (0.1%). It holds 4 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is GIOTX's 5-year return?
GIOTX returned +13.4% a year over the five years ending Dec 31, 2025, and +10.1% a year over ten years. Past performance does not guarantee future results.
Who manages GIOTX?
GIOTX is offered by Gmo through Gmo Trust.